Modified R-DAOx as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma

被引：0
|
作者：
Rigacci, L. [1 ]
Fabbri, A. [2 ]
Mappa, S. [1 ]
Nassi, L. [1 ]
Lenoci, M. [2 ]
Puccini, B. [1 ]
Alterini, R. [1 ]
Chitarrelli, I [2 ]
Carrai, V [1 ]
Lauria, F. [2 ]
Bosi, A. [1 ]
机构：
[1] Univ Florence, Florence Azienda Osped, Dept Hematol, I-50121 Florence, Italy
[2] Univ Siena, Siena Azienda Osped, Dept Hematol, I-53100 Siena, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [41] Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients
    Nikolett, Wohner
    Gergely, Varga
    Peter, Szloboda
    Peter, Farkas
    Andras, Masszi
    Laura, Horvath
    Gergely, Szombath
    Judit, Varkonyi
    Szabolcs, Benedek
    Tamas, Masszi
    [J]. ORVOSI HETILAP, 2017, 158 (41) : 1642 - 1648
  • [42] Outcome of salvage therapy for relapsed or refractory peripheral T-cell lymphoma (PTCL), anaplastic large cell lymphoma (ALCL), and diffuse large B-cell lymphoma (DLBCL).
    Wu, G.
    Kuruvilla, J.
    Nagy, T.
    Keating, A.
    Crump, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 348S - 348S
  • [43] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Charanpreet Singh
    Aditya Jandial
    Arihant Jain
    Deepesh Lad
    Alka Khadwal
    Rajender Basher
    Amanjit Bal
    Pankaj Malhotra
    Gaurav Prakash
    [J]. Indian Journal of Hematology and Blood Transfusion, 2024, 40 : 231 - 236
  • [44] Challenges in Administering Salvage Therapy and Outcomes of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients: A LMIC Real-World Study
    Singh, Charanpreet
    Jandial, Aditya
    Jain, Arihant
    Lad, Deepesh
    Khadwal, Alka
    Basher, Rajender
    Bal, Amanjit
    Malhotra, Pankaj
    Prakash, Gaurav
    [J]. INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024, 40 (02) : 231 - 236
  • [45] Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation
    Salido Toimil, F.
    Torres Carrete, P.
    Deben Ariznavarreta, G.
    Varela Gomez, M. R.
    Lopez Fernandez, M. F.
    Noriega Concepcion, V.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S300 - S301
  • [46] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    [J]. LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
  • [47] Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy
    Tun, Aung M.
    Wang, Yucai
    Maliske, Seth
    Micallef, Ivana
    Inwards, David J.
    Habermann, Thomas M.
    Porrata, Luis
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Rosenthal, Allison
    Kharfan-Dabaja, Mohamed A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    [J]. REVISTA CHILENA DE LITERATURA, 2024, (109): : 2186 - 2195
  • [48] Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy
    Tun, Aung M.
    Wang, Yucai
    Maliske, Seth
    Micallef, Ivana
    Inwards, David J.
    Habermann, Thomas M.
    Porrata, Luis
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Rosenthal, Allison
    Kharfan-Dabaja, Mohamed A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    [J]. HAEMATOLOGICA, 2024, 109 (07) : 2186 - 2195
  • [49] Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The ORCHARRD Study
    van Imhoff, Gustaaf W.
    McMillan, Andrew
    Matasar, Matthew J.
    Radford, John
    Ardeshna, Kirit M.
    Kuliczkowski, Kazimierz
    Kim, WonSeog
    Hong, Xiaonan
    Goerloev, Jette Soenderskov
    Davies, Andrew
    Caballero Barrigon, Maria Dolores
    Ogura, Michinori
    Leppa, Sirpa
    Fennessy, Michael
    Liao, Qiming
    van der Holt, Bronno
    Lisby, Steen
    Hagenbeek, Anton
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05) : 544 - +
  • [50] A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
    Kalakonda, Nagesh
    Cavallo, Federica
    Follows, George
    Goy, Andre
    Vermaat, Joost S. P.
    Casasnovas, Olivier
    Lavee, Orly
    Maerevoet, Marie
    Zijlstra, Josee
    Bakhshi, Sameer
    Bouabdallah, Reda
    Choquet, Sylvain
    Gurion, Ronit
    Hill, Brian
    Jaeger, Ulrich
    Sancho, Juan-Manuel
    Schuster, Michael
    Thieblemont, Catherine
    De la Cruz, Fatima
    Egyed, Miklos
    Mishra, Sourav
    Offner, Fritz
    Vassilakopoulos, Theodoros
    Warzocha, Krzysztof
    McCarthy, Daniel
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita
    Shah, Jatin
    Van den Neste, Eric
    Canales, Miguel
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S248 - S249
12345